Raymond James Trust N.A. trimmed its stake in Koninklijke Philips (NYSE:PHG – Free Report) by 28.0% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 16,196 shares of the technology company’s stock after selling 6,307 shares during the quarter. Raymond James Trust N.A.’s holdings in Koninklijke Philips were worth $530,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in PHG. Charles Schwab Investment Management Inc. grew its position in shares of Koninklijke Philips by 26.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 55,290 shares of the technology company’s stock valued at $1,809,000 after acquiring an additional 11,538 shares during the period. West Family Investments Inc. bought a new position in shares of Koninklijke Philips during the third quarter worth approximately $252,000. PNC Financial Services Group Inc. lifted its holdings in Koninklijke Philips by 4.8% during the 3rd quarter. PNC Financial Services Group Inc. now owns 36,291 shares of the technology company’s stock worth $1,187,000 after purchasing an additional 1,676 shares during the last quarter. Endowment Wealth Management Inc. bought a new stake in Koninklijke Philips in the 3rd quarter valued at $205,000. Finally, Cable Hill Partners LLC acquired a new position in Koninklijke Philips in the 3rd quarter valued at $203,000. Institutional investors and hedge funds own 13.67% of the company’s stock.
Koninklijke Philips Stock Up 3.0 %
PHG stock opened at $27.18 on Tuesday. Koninklijke Philips has a 52 week low of $19.49 and a 52 week high of $32.91. The business has a 50-day simple moving average of $29.56 and a 200 day simple moving average of $28.28. The company has a quick ratio of 0.74, a current ratio of 1.16 and a debt-to-equity ratio of 0.60. The company has a market cap of $25.55 billion, a PE ratio of -64.71, a price-to-earnings-growth ratio of 0.93 and a beta of 0.77.
Analyst Ratings Changes
Get Our Latest Research Report on Koninklijke Philips
Koninklijke Philips Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Further Reading
- Five stocks we like better than Koninklijke Philips
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- Find and Profitably Trade Stocks at 52-Week Lows
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Using the MarketBeat Dividend Tax Calculator
- Discover the 3 Best Performing Stocks That Went Public in 2024
Want to see what other hedge funds are holding PHG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Koninklijke Philips (NYSE:PHG – Free Report).
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.